Innovation Pharmaceuticals Inc.
IPIX
$0.0002
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 38.38% | 58.12% | 53.03% | 80.73% | 30.54% |
| Total Depreciation and Amortization | 1.08% | -3.13% | -2.11% | -2.08% | -2.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -67.94% | -82.29% | -79.61% | 275.00% | 422.50% |
| Change in Net Operating Assets | -87.46% | 168.09% | 46.88% | 45.56% | 1,115.15% |
| Cash from Operations | 14.41% | 61.48% | 58.16% | 78.77% | 59.52% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.00% | 99.70% | -183.33% | 0.00% | 76.47% |
| Cash from Investing | 50.00% | 99.70% | -183.33% | 0.00% | 76.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 99.13% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 156.82% | -- | -- | -104.14% | -101.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.05% | 91.54% | 57.14% | 57.55% | -182.91% |